CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy
Clearside Biomedical filed for Chapter 11 bankruptcy Monday and will seek a court-supervised sale of its assets. CLSD stock plunged nearly 68% to around $0.88 by late afternoon, hitting a new 52-week low after closing at $2.69 Friday. Trading volume spiked to roughly 12 times normal levels. The company cited “substantial doubt” about its ability to continue as a going concern in its latest quarterly filing.
